Home › Funds › Beau Ventures, LLc › MRNA
Beau Ventures, LLc position in MRNA
MODERNA INC · Health Care
Beau Ventures, LLc reported holding 1,000,056 shares of MRNA (MODERNA INC) in its Q3 2026 13F filing — a position valued at US$192.6M, representing 18.17% of its reported portfolio and ranking #2 among its reported holdings. Beau Ventures, LLc has disclosed MRNA holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Beau Ventures, LLc's MRNA position evolved
Beau Ventures, LLc first disclosed a stake in MRNA in Q4 2025 at 1,000,106 shares (US$29.5M). The position peaked in Q3 2026 at 1,000,056 shares, worth US$192.6M. Across 4 filings, Beau Ventures, LLc held the position steady without any share-count change. The most recent filing (Q3 2026) shows 1,000,056 shares valued at US$192.6M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 1.00M | $29.49M | New |
| Q1 2026 | 1.00M | $50.81M | Hold |
| Q2 2026 | 1.00M | $70.04M | Hold |
| Q3 2026 | 1.00M | $192.58M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About MRNA and 13F data
MRNA (MODERNA INC) is a Health Care company. 36 other funds we track also report a position in MRNA — the largest reported positions include Baillie Gifford & Co (US$1.28B), Theleme Partners LLP (US$564.3M), BANQUE PICTET & CIE SA (US$414.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding MRNA
- Baillie Gifford & Co 18.21M sh · $1.28B · Q2 2026
- Theleme Partners LLP 8.06M sh · $564.27M · Q2 2026
- BANQUE PICTET & CIE SA 2.15M sh · $414.27M · Q3 2026
- Flagship Pioneering, LLC 4.63M sh · $324.39M · Q2 2026
- Douglas Lane & Associates, LLC 1.16M sh · $223.56M · Q3 2026
- Merck & Co., Inc. 2.31M sh · $161.64M · Q2 2026
- Baron Funds 1.99M sh · $139.32M · Q2 2026
- BAMCO INC /NY/ 1.99M sh · $139.32M · Q2 2026
- IMC-Chicago, LLC 1.70M sh · $119.21M · Q2 2026
More on Beau Ventures, LLc
FAQ
How long has Beau Ventures, LLc held MRNA?
Beau Ventures, LLc has disclosed MRNA holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is Beau Ventures, LLc's current position in MRNA?
As of Q3 2026, Beau Ventures, LLc holds 1.00M shares of MRNA (MODERNA INC), valued at $192.58M, representing 18.17% of its reported portfolio and ranking #2.
Has Beau Ventures, LLc been buying or selling MRNA?
In the latest 13F filing (Q3 2026), Beau Ventures, LLc held unchanged its position in MRNA. The position peaked in Q3 2026 at 1.00M shares.
Which other funds hold MRNA?
Other major institutional holders of MRNA include Baillie Gifford & Co, Theleme Partners LLP, BANQUE PICTET & CIE SA, among 36 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.